A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The objectives of this study are to compare the efficacy and safety of tanfanercept ophthalmic solution 0.25% and 1.0% to vehicle for the treatment of DED.
Epistemonikos ID: 5a02f681562a2d1c27aeb4d3d9861b566274d0b9
First added on: May 22, 2024